Carl Weissman
Amministratore Delegato presso ISB Accelerator Corp.
Profilo
Carl Weissman is the founder of Accelerator Services Corp, which was founded in 2003.
He is currently the Chief Executive Officer at ISB Accelerator Corp.
Mr. Weissman's former positions include President & Chief Executive Officer at Homestead Clinical Corp., Director at Allozyne, Inc., Groove Biopharma Corp., Oncofactor Corp., Viral Logic Systems Technology Corp., and Novomer, Inc. He was also a Director at Fate Therapeutics, Inc. and a Venture Partner at MPM BioImpact, Inc. Additionally, he served as President & Director at Acylin Therapeutics, Inc. and President at XORI Corp.
Mr. Weissman briefly served as President at Nevis Brands, Inc. in 2019.
Posizioni attive di Carl Weissman
| Società | Posizione | Inizio |
|---|---|---|
ISB Accelerator Corp.
 ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services ISB Accelerator Corp. is involved in the study of biological systems to help identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The company is located in Seattle, WA. | Amministratore Delegato | 01/01/2003 |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Fondatore | 19/01/2011 |
Precedenti posizioni note di Carl Weissman
| Società | Posizione | Fine |
|---|---|---|
| NEVIS BRANDS INC. | Presidente | 04/07/2019 |
Homestead Clinical Corp.
 Homestead Clinical Corp. Pharmaceuticals: MajorHealth Technology Homestead Clinical Corp. develops pharmaceutical products. It develops diagnostic, prognostic, and theranostic tools which is used for the diseases such as cancer, diabetes, and AIDS. The company was founded by Leroy E. Hood in June 2005 and is headquartered in Seattle, WA. | Presidente | 27/11/2009 |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investitore di Private Equity | 30/06/2008 |
Novomer, Inc.
 Novomer, Inc. Industrial SpecialtiesProcess Industries Novomer, Inc. manufactures biodegradable plastics, polymers, and other chemicals from renewable substances. It specializes in commercializing a family of low-cost, high-performance, sustainable polymers and other chemicals. The company was founded by Geoffrey William Coates, Anthony Romey Eisenhut and Scott D. Allen in 2004 and is headquartered in Waltham, MA. | Direttore/Membro del Consiglio | - |
Acylin Therapeutics, Inc.
 Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA. | Presidente | 26/04/2013 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| NEVIS BRANDS INC. | Health Technology |
| Aziende private | 11 |
|---|---|
ISB Accelerator Corp.
ISB Accelerator Corp. Miscellaneous Commercial ServicesCommercial Services ISB Accelerator Corp. is involved in the study of biological systems to help identify strategies for predicting and preventing diseases such as cancer, diabetes and AIDS. The company is located in Seattle, WA. | Commercial Services |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Homestead Clinical Corp.
Homestead Clinical Corp. Pharmaceuticals: MajorHealth Technology Homestead Clinical Corp. develops pharmaceutical products. It develops diagnostic, prognostic, and theranostic tools which is used for the diseases such as cancer, diabetes, and AIDS. The company was founded by Leroy E. Hood in June 2005 and is headquartered in Seattle, WA. | Health Technology |
Allozyne, Inc.
 Allozyne, Inc. Medical SpecialtiesHealth Technology Allozyne, Inc. operates as a biotechnology company that develops and manufactures pharmaceutical products. The firm focuses on manufacture of protein therapeutics for the medical need in autoimmune diseases and cancer. The company was founded by David A. Tirrell, Deepshikha Datta, and William A. Goddard, III in March 2004 and is headquartered in Seattle, WA. | Health Technology |
Oncofactor Corp.
 Oncofactor Corp. Pharmaceuticals: MajorHealth Technology Oncofactor Corp. develops antibody drugs against new biologic targets in cancer. Its cancer therapeutics that disrupt signaling pathways between tumors and the immune system. The company was founded by Sarah Ellen Warren in 2011 and is headquartered in Seattle, WA. | Health Technology |
XORI Corp.
 XORI Corp. BiotechnologyHealth Technology XORI Corp. provides health technology services. It develops technology for the rapid discovery and development of monoclonal antibodies (MAbs). The firm validates the technology on a variety of targets and develops superior products for cancer therapy, immune disorders, and infectious diseases. The company was founded by Nancy Maizels in 2009 and is headquartered in Seattle, WA. | Health Technology |
Groove Biopharma Corp.
 Groove Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Groove Biopharma Corp. focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) were involved in extensive regulatory networks for many target genes and pathways. Groove Biopharma's core technology addressed a new avenue of nucleotide therapeutic drug discovery via modulation of cellular mirna. Used exclusive technology, Groove Biopharma were generated a series of lead candidates with the potential to be best-in-class therapeutics. By incorporated proprietary structural modifications into miRNA therapeutics, the Groove Biopharma technology platform presented promising potential for treating a wide range of diseases, including cancer, fibrosis, and infectious disease.The company was founded in 2008 and is headquartered in Seattle,UN. | Commercial Services |
Viral Logic Systems Technology Corp.
 Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Health Technology |
Acylin Therapeutics, Inc.
Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA. | Health Technology |
Novomer, Inc.
Novomer, Inc. Industrial SpecialtiesProcess Industries Novomer, Inc. manufactures biodegradable plastics, polymers, and other chemicals from renewable substances. It specializes in commercializing a family of low-cost, high-performance, sustainable polymers and other chemicals. The company was founded by Geoffrey William Coates, Anthony Romey Eisenhut and Scott D. Allen in 2004 and is headquartered in Waltham, MA. | Process Industries |
- Borsa valori
- Insiders
- Carl Weissman
